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Now that the human genome is completed, the characterization of the proteins encoded by the sequence remains a challenging
task. The study of the complete protein complement of the genome, the “proteome,” referred to as proteomics, will be essential if
new therapeutic drugs and new disease biomarkers for early diagnosis are to be developed. Research eﬀorts are already underway to
develop the technology necessary to compare the speciﬁc protein proﬁles of diseased versus nondiseased states. These technologies
provide a wealth of information and rapidly generate large quantities of data. Processing the large amounts of data will lead to
useful predictive mathematical descriptions of biological systems which will permit rapid identiﬁcation of novel therapeutic targets
and identiﬁcation of metabolic disorders. Here, we present an overview of the current status and future research approaches in
deﬁning the cancer cell’s proteome in combination with diﬀerent bioinformatics and computational biology tools toward a better
understanding of health and disease.
TECHNOLOGIES FOR PROTEOMICS
2Dgelelectrophoresis
Two-dimensional gel electrophoresis (2DE) is by far
the most widely used tool in proteomics approaches for
m o r et h a n2 5y e a r s[ 1]. This technique involves the sep-
aration of complex mixtures of proteins ﬁrst on the basis
of isoelectric point (pI) using isoelectric focusing (IEF)
andtheninaseconddimensionbasedonmolecularmass.
The proteins are separated by migration in a polyacry-
lamide gel. By use of diﬀerent gel staining techniques
such as silver staining [2], Coomassie blue stain, ﬂuores-
cent dyes [3], or radiolabels, few thousands proteins can
be visualized on a single gel. Fluorescent dyes are being
developed to overcome some of the drawbacks of silver
staining in making the protein samples more amenable
to mass spectrometry [4, 5]. Stained gels can then be
scanned at diﬀerent resolutions with laser densitometers,
ﬂuorescent imager, or other device. The data can be ana-
lyzed with software such as PDQuest by Bio-Rad Labora-
tories (Hercules, Calif, USA) [6], Melanie 3 by GeneBio
(Geneva, Switzerland), Imagemaster 2D Elite by Amer-
sham Biosciences, and DeCyder 2D Analysis by Amer-
shamBiosciences(Buckinghamshire,UK)[7].Ratioanal-
ysis is used to detect quantitative changes in proteins be-
tween two samples. 2DE is currently being adapted to
high-throughput platforms [8]. For setting up a high-
throughput environment for proteome analysis, it is es-
sential that the 2D gel image analysis software supports
robust database tools for sorting images, as well as data
from spot analysis, quantiﬁcation, and identiﬁcation.
ProteinChips
While proteomics has become almost synonymous
with2Dgelelectrophoresis,thereisavarietyofnewmeth-
ods for proteome analysis. Unique ionization techniques,
such as electrospray ionization and matrix-assisted laser
desorption-ionization(MALDI),havefacilitatedthechar-
acterization of proteins by mass spectrometry (MS) [9,
10]. These techniques have enabled the transfer of the
proteins into the gas phase, making it conducive for their
analysis in the mass spectrometer. Typically, sequence-
speciﬁc proteases are used to break up the proteins into
peptides that are coprecipitated with a light-absorbing
matrix such as dihydroxy benzoic acid. The peptides are
then subjected to short pulses of ultraviolet radiation
under reduced pressure. Some of the peptides are ion-
i z e da n da c c e l e r a t e di na ne l e c t r i cﬁ e l da n ds u b s e q u e n t l y
turned back through an energy correction device [11].
Peptide mass is derived through a time-of-ﬂight (TOF)
measurement of the elapsed time from acceleration-to-
ﬁeld free drift or through a quadrupole detector. A pep-
tide mass map is generated with the sensitivity to detect
molecules at a few parts per million. Hence a spectrum
is generated with the molecular mass of individual pep-
tides, which are used to search databases to ﬁnd match-
ing proteins. A minimum of three peptide molecular
weights is necessary to minimize false-positive matches.218 H. Bensmail and A. Haoudi 2003:4 (2003)
The principle behind peptide mass mapping is the match-
ing of experimentally generated peptides with those de-
termined for each entry in a sequence. The alternative
process of ionization, through the electrospray ioniza-
tion, involves dispersion of the sample through a cap-
illary device at high voltage [11]. The charged peptides
pass through a mass spectrometer under reduced pressure
andareseparatedaccordingtotheirmass-to-chargeratios
through electric ﬁelds. After separation through 2DE, di-
gested peptide samples can be delivered to the mass spec-
trometer through a “nanoelectrospray” or directly from a
liquid chromatography column (liquid chromatography-
MS), allowing for real-time sequencing and identiﬁcation
of proteins. Recent developments have led to the MALDI
quadrupole TOF instrument, which combines peptide
mapping with peptide sequencing approach [12, 13, 14].
An important feature of tandem MS (MS-MS) analy-
sis is the ability to accurately identify posttranslational
modiﬁcations,suchasphosphorylationandglycosylation,
through the measurement of mass shifts.
Another MS-based proteinChip technology, surface-
enhanced laser desorption-ionization time of ﬂight mass
spectrometry (SELDI-TOF-MS), has been successfully
used to detect several disease-associated proteins in com-
plex biological specimens, such as cell lysates, seminal
plasma, and serum [15, 16, 17]. Surface-enhanced laser
desorption-ionization (SELDI) is an aﬃnity-based MS
method in which proteins are selectively adsorbed to a
chemically modiﬁed surface, and impurities are removed
by washing with buﬀer. The use of several diﬀerent chro-
matographic arrays and wash conditions enables high-
speed,high-resolutionchromatographicseparations[14].
Othertechnologies
Arrays of peptides and proteins provide another bio-
chip strategy for parallel protein analysis. Protein assays
using ordered arrays have been explored through the de-
velopment of multipin synthesis [18]. Arrays of clones
from phage-display libraries can be probed with antigen-
coated ﬁlters for high-throughput antibody screening
[19]. Proteins covalently attached to glass slides through
aldehyde-containing silane reagents have been used to de-
tect protein-protein interactions, enzymatic targets, and
protein small molecule interactions [20]. Other meth-
ods of generating protein microarrays are by printing the
proteins (ie, puriﬁed proteins, recombinant proteins, and
crude mixtures) or antibodies using a robotic arrayer and
a coated microscope slide in an ordered array. Protein so-
lutions to be measured are labeled by covalent linkage of a
ﬂuorescent dye to the amino groups on the proteins [21].
Protein arrays consisting of immobilized proteins from
pure populations of microdissected cells have been used
to identify and track cancer progression. Although pro-
tein arrays hold considerable promise for functional pro-
teomics and expression proﬁling for monitoring a disease
state, certain limitations need to be overcome. These in-
clude the development of high-throughput technologies
to express and purify proteins and the generation of large
sets of well-characterized antibodies. Generating protein
andantibodyarraysismorecostlyandlabor-intensiverel-
ative to DNA arrays. Nevertheless, the availability of large
antibody arrays would enhance the discovery of diﬀeren-
tial biomarkers in nondiseased and cancer tissue [22].
Tissue arrays have been developed for high-
throughput molecular proﬁling of tumor specimens
[23]. Arrays are generated by robotic punching out of
small cylinders (0.6mm× 3–4mm high) of tissue from
thousands of individual tumor specimens embedded in
paraﬃnt oa r r a yt h e mi nap a r a ﬃn block. Tissue from
as many as 600 specimens can be represented in a single
“master” paraﬃn block. By use of serial sections of the
tissue array, tumors can be analyzed in parallel by im-
munohistochemistry, ﬂuorescence in situ hybridization,
and RNA-RNA in situ hybridization. Tissue arrays have
applications in the simultaneous analysis of tumors from
many diﬀerent patients at diﬀerent stages of disease.
Disadvantages of this technique are that a single core is
not representative because of tumor heterogeneity and
uncertainty of antigen stability on long-term storage
of the array. Hoos et al [24] demonstrated that using
triplicate cores per tumor led to lower numbers of lost
cases and lower nonconcordance with typical full sections
relative to one or two cores per tumor. Camp et al [25]
found no antigenic loss after storage of an array for 3
months. Validation of tissue microarrays is currently on-
going in breast and prostate cancers and will undoubtedly
help in protein expression proﬁling [23, 25, 26]. A major
advantage of this technology is that expression proﬁles
can be correlated with outcomes from large cohorts in a
matter of few days.
PROTEOMICS IN CANCER RESEARCH
Cancer proteomics encompasses the identiﬁcation
and quantitative analysis of diﬀerentially expressed pro-
teins relative to healthy tissue counterparts at diﬀerent
stages of disease, from preneoplasia to neoplasia. Pro-
teomic technologies can also be used to identify mark-
ers for cancer diagnosis, to monitor disease progression,
and to identify therapeutic targets. Proteomics is valuable
in the discovery of biomarkers because the proteome re-
ﬂectsboththeintrinsicgeneticprogramofthecellandthe
impact of its immediate environment. Protein expression
and function are subject to modulation through tran-
scription as well as through posttranscriptional and post-
translational events. More than one RNA can result from
one gene through a process of diﬀerential splicing. Addi-
tionally, there are more than 200 posttranslation modiﬁ-
cations that proteins could undergo, that aﬀect function,
protein-protein and nuclide-protein interaction, stability,
targeting, half-life, and so on [27], all contributing to a
potentially large number of protein products from one
gene. At the protein level, distinct changes occur during
the transformation of a healthy cell into a neoplastic cell,2003:4 (2003) Postgenomics: Proteomics and Bioinformatics in Cancer Research 219
rangingfromalteredexpression,diﬀerentialproteinmod-
iﬁcation, and changes in speciﬁc activity, to aberrant lo-
calization, all of which may aﬀect cellular function. Iden-
tifying and understanding these changes are the underly-
ing themes in cancer proteomics. The deliverables include
identiﬁcationofbiomarkersthathaveutilitybothforearly
detection and for determining of therapy.
Although proteomics traditionally dealt with quanti-
tative analysis of protein expression, more recently, pro-
teomics has been viewed to encompass the structural
analysis of proteins [28]. Quantitative proteomics strives
to investigate the changes in protein expression in diﬀer-
ent states, such as in healthy and diseased tissue or at dif-
ferent stages of the disease. This enables the identiﬁca-
tion of state- and stage-speciﬁc proteins. Structural pro-
teomics attempts to uncover the structure of proteins and
to unravel and map protein-protein interactions.
MS has been helpful in the analysis of proteins from
cancer tissues. Screening for the multiple forms of the
molecular chaperone 14-3-3 protein in healthy breast ep-
ithelial cells and breast carcinomas yielded a potential
marker for the noncancerous cells [29]. The 14-3-3 form
was observed to be strongly down regulated in primary
breast carcinomas and breast cancer cell lines relative to
healthy breast epithelial cells. This ﬁnding, in the light of
theevidencethatthegenefor14-3-3wasfoundsilencedin
breast cancer cells [30], implicates this protein as a tumor
suppressor.UsingaMALDI-MSsystem,Bergmanetal[6]
detectedincreasesintheexpressionsofnuclearmatrix,re-
dox, and cytoskeletal proteins in breast carcinoma relative
to benign tumors. Fibroadenoma exhibited an increase in
the oncogene product DJ-1. Retinoic acid-binding pro-
tein, carbohydrate-binding protein, and certain lipopro-
teins were increased in ovarian carcinoma, whereas
cathepsin D was increased in lung adenocarcinoma.
Imaging MS is a new technology for direct mapping
and imaging of biomolecules present in tissue sections.
For this system, frozen tissue sections or individual cells
are mounted on a metal plate, coated with ultraviolet-
absorbing matrix, and placed in the MS. With the use
of an optical scanning raster over the tissue specimen
and measurement of the peak intensities over thousands
of spots, MS images are generated at speciﬁc mass val-
ues [31]. Stoeckli et al [32] used imaging MS to exam-
ine protein expression in sections of human glioblastoma
and found increased expression of several proteins in the
proliferating area compared with healthy tissue. Liquid
chromatography—MS and tandem MS (MS-MS) were
used to identify thymosin ß.4, a 4964-d protein found
only in the outer proliferating zone of the tumor [32].
Imaging MS shows potential for several applications, in-
cluding biomarker discovery, biomarker tissue localiza-
tion, understanding of the molecular complexities of tu-
mor cells, and intraoperative assessment of surgical mar-
gins of tumors.
SELDI,originallydescribedbyHutchensandYip[33],
overcomes many of the problems associated with sample
preparations inherent with MALDI-MS. The underlying
principle in SELDI is surface-enhanced aﬃnity capture
through the use of speciﬁc probe surfaces or chips. This
protein biochip is the counterpart of the array technol-
ogy in the genomic ﬁeld and also forms the platform for
Ciphergen’s ProteinChip array SELDI MS system [14]. A
2DE analysis separation is not necessary for SELDI anal-
ysis because it can bind protein molecules on the basis of
its deﬁned chip surfaces. Chips with broad binding prop-
erties, including immobilized metal aﬃnity capture, and
with biochemically characterized surfaces, such as anti-
bodies and receptors, form the core of SELDI. This MS
technology enables both biomarker discovery and pro-
tein proﬁling directly from the sample source without
preprocessing. Sample volumes can be scaled down to
as low as 0.5µL, an advantage in cases in which sam-
ple volume is limiting. Once captured on the SELDI
protein biochip array, proteins are detected through the
ionization-desorption TOF-MS process. A retentate (pro-
teins retained on the chip) map is generated in which the
individual proteins are displayed as separate peaks on the
basis of their mass and charge (m/z). Wright et al [15]
demonstrated the utility of the ProteinChip SELDI-MS in
identifying known markers of prostate cancer and in dis-
coveringpotentialmarkerseitherover-orunderexpressed
in prostate cancer cells and body ﬂuids. SELDI analyses
of cell lysates prepared from pure populations from mi-
crodissected surgical tissue specimens revealed diﬀeren-
tially expressed proteins in the cancer cell lysate when
compared with healthy cell lysates and with benign pro-
static hyperplasia (BPH) and prostate intraepithelial neo-
plasia cell lysates [15]. SELDI is a method that provides
protein proﬁles or patterns in a short period of time from
a small starting sample, suggesting that molecular ﬁnger-
prints may provide insights into changing protein expres-
sion from healthy to benign to premalignant to malignant
lesions.ThisappearstobethecasebecausedistinctSELDI
protein proﬁles for each cell and cancer type evaluated,
including prostate, lung, ovarian, and breast cancer, have
been described recently [34, 35]. After prefractionation,
a SELDI proﬁle of 30 dysregulated proteins was observed
in seminal plasma from prostate cancer patients. One of
the seminal plasma proteins detected by comparing the
p r o s t a t ec a n c e rp r o ﬁ l e sw i t haB P Hp r o ﬁ l ew a si d e n t i -
ﬁed as seminal basic protein, a proteolytic product of se-
menogelin I [14].
BIOINFORMATICS TOOLS
Bioinformatics tools are needed at all levels of pro-
teomic analysis. The main databases serving as the tar-
gets for MS data searches are the expressed sequence
tag and the protein sequence databases, which contain
protein sequence information translated from DNA se-
quence data [11]. It is thought that virtually any pro-
tein that can be detected on a 2D gel can be identi-
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contains over 2 million cDNA sequences [36]. A modiﬁ-
cation of sequence-tag algorithms has been shown to lo-
cate peptides given the fact that the expressed sequence
tags cover only a partial sequence of the protein [37].
Dataminingforproteomics
A number of algorithms have been proposed for
genomes-scale analysis of patterns of gene expression, in-
cluding expressed sequence tags (ESTs) (simple expedi-
ent of counting), UniGene for gene indexes [38]. Going
beyond expression data, eﬀorts in proteomics can be ex-
pressedtoﬁllinamorecompletepictureofposttranscrip-
tional events and the overall protein content of cells. To
address the large-in-scale data, this review addresses pri-
marily those advances in recent years.
Concurrent to the development of the genome se-
quences for many organisms, MS has become a valuable
technique for the rapid identiﬁcation of proteins and is
now astandardmoresensitiveandmuchfasteralternative
to the more traditional approaches to sequencing such as
Edman degradation.
Due to the large array of data that is generated from
a single analysis, it is essential to implement the use
of algorithms that can detect expression patterns from
such large volumes of data correlating to a given biologi-
cal/pathological phenotype from multiple samples. It en-
ables the identiﬁcation of validated biomarkers correlat-
ing strongly to disease progression. This would not only
classify the cancerous and noncancerous tissues accord-
ing to their molecular proﬁle but could also focus atten-
tion upon a relatively small number of molecules that
might warrant further biochemical/molecular character-
ization to assess their suitability as potential therapeutic
targets.Datascreenedisusuallyoflargesizeandhasabout
100000–120000 variables.
Biologists are not prepared to handle the huge data
produced by the proteins or DNA microarray projects
or to use the “eye” to visualize and interpret the output,
thereforetodetectpattern,visualize,classify,andstorethe
data, more sophisticated tools are needed. Bioinformatics
has proved to be a powerful tool in the eﬀective genera-
tion of primarily predictive proteomic data from analysis
of DNA sequences. Proteomics studies applications and
techniques, includes proﬁling expression patterns in re-
sponse to various variables and conditions and time cor-
relation analysis of protein expression.
Intelligent data mining facilities are essential if we are
topreventimportantresultsfrombeinglostinthemassof
information. The analysis of data can proceed with diﬀer-
entlevels.Onelevelofdiﬀerentialanalysiswheregenesare
analyzed one by one independently of each other to detect
changes in expression across diﬀerent conditions. This
is challenging due to the amount of noise involved and
low repetition characteristic of microarray experiments.
The next level of analysis involves visualizing and fea-
ture discovery. Basic statistical tools and statistical infer-
ences include cluster analysis, Bayesian modeling, classiﬁ-
cation, and discrimination, neural networks, and graph-
ical models. The basic idea behind those approaches is
to visualize the correlations in the data to allow the data
to be examined for similarity and detection of impor-
tant expression patterns (principal component analysis)
to learn (classiﬁcation, neural networks, support vector
machine), to predict (prediction, regression, regression
tree),todetectfeaturediscovery,andtotesthypothesesre-
garding the number of distinct clusters contained within
the data (hierarchical clustering, Bayesian clustering, k-
means, mixture model with Gibbs sampler or EM algo-
rithm).
These algorithms can quickly analyze gels to identify
how a series of gels are related, for example, conﬁrming
separation of clusters into healthy (control), diseased, and
treatments clusters, or perhaps pointing to the existence
of a cluster which has not previously been considered,
which is a population of cells exhibiting drug resistance
[39, 40].
Principalcomponentanalysis
Principal component analysis (PCA) can be an eﬀec-
tive method of identifying the most discriminating fea-
tures in a data set. This technique usually involves ﬁnd-
ing two or three linear combinations of the original fea-
tures that best summarize the types of variation in the
data. If much of the variation is captured by these two or
three most signiﬁcant principal components, class mem-
bership of many data points can be observed. One may
use the principal-component solution to the factor model
for extracting factors (components). This is accomplished
by the use of the principal-axis theorem, which says that
for a gene-by-gene (n ×n) correlation matrix R, there ex-
ists a rotation matrix D and diagonal matrix Λ such that
DRDt = Λ. The principal form of R is given as
R(n×n) = DΛDt
(n×n)
=

    

d11 d12 ··· d1m
d21 d22 ··· d2m
. . .
. . . ···
. . .
dn1 dn2 ··· dnm

    

×

    

λ1 0 ··· 0
0 λ2 ··· 0
. . .
. . . ···
. . .
00 ··· λm

    


    

d11 d12 ··· d1m
d21 d22 ··· d2m
. . .
. . . ···
. . .
dn1 dn2 ··· dnm

    

,
(1)
wherecolumnsofD and Dt are the eigenvectors and diag-
onal entries of Λ are the eigenvalues. Components whose
eigenvalues exceed unity, λj > 1, are extracted from Λ and
sorted such that λ1 ≥ λ2 ≥···≥λm ≥ 1. The “loading”
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represented by a matrix in the form
L(n×m) =

    

 
λ1d11
 
λ2d12 ···
 
λmd1m  
λ1d21
 
λ2d22 ···
 
λmd2m
. . .
. . . ···
. . .
 
λ1dn1
 
λ2dn2 ···
 
λmdnm

    

, (2)
where rows represent genes and columns represent com-
ponents, and, for example,
 
λ1d11 is the loading (correla-
tion) between gene 1 and component 1. CLUSFAVOR al-
gorithm proposed by Leif [41] performs PCA along with
hierarchical clustering (see “Hierarchical clustering and
decision tree” section) with DNA microarray expression
data. CLUSFAVOR standardizes expression data and sorts
and performs hierarchical and PCA of arrays and genes.
Applying CLUSFAVOR, principal component method is
used and component extraction and loading calculations
are completed, a varimax orthogonal rotation of com-
ponents is completed so that each gene mostly loads on
a single component [42]. The result reported in [41]
mixing hierarchical clustering and PCS was summarized
through a colored tree, where genes that load strongly
negative (less than −0.45) or strongly positive (greater
than 0.45) on a single component are indicated by the
use of two arbitrary colors in the column for each com-
ponent whereas genes with identical color patterns in one
or more columns were considered as having similar ex-
pression proﬁles within the selected group of genes.
Unsupervisedlearningbasedonnormalmixturemodels
Unsupervised clustering is used to detect pattern, fea-
ture discovery, and also to match the protein sequence
to the database sequences. Unsupervised learning enables
pattern discovery by organizing data into clusters, using
recursive partitioning methods. In the last 25 years it has
been found that basing cluster analysis on a probability
model can be useful both for understanding when exist-
ing methods are likely to be successful and for suggesting
new methods [43, 44, 45, 46, 47, 48, 49]. One such proba-
bilitymodelisthatthepopulationofinterestconsistsof K
diﬀerent subpopulations G1,...,G K and that the density
of a p-dimensional observation x from the kth subpopu-
lation is fk(x,θ k) for some unknown vector of parameters
θk (k = 1,...,K). Given observations x = (x1,...,xn), we
let ν = (ν1,...,νn)t denote the unknown identifying la-
bels, where νi = k if xi comes from the kth subpopulation.
In the so-called classiﬁcation maximum likelihood proce-
dure, θ = (θ1,...,θ K)a n dν = (ν1,...,νn)t are chosen to
maximize the classiﬁcation likelihood:
p
 
θ1,...,θ K;ν1,...,νn|x
 
=
n  
i=1
fνi
 
xi|θνi
 
. (3)
Normal mixture is a traditional statistical tool which
has successfully been applied in gene expression [50]. For
multivariatedataofacontinuousnature,attentionhasfo-
cused on the use of multivariate normal components be-
causeoftheircomputationalconvenience.Inthiscase,the
data x = (x1,...,xn) to be classiﬁed are viewed as coming
from a mixture of probability distributions, each repre-
senting a diﬀerent cluster, so the likelihood is expressed
as
p
 
θ1,...,θ K;π1,...,π K|x
 
=
n  
i=1
K  
k=1
πk fk
 
xi|θk
 
, (4)
where πk is the probability that an observation belongs to
the kth components (πk ≥ 0;
 K
k=1πk = 1).
In the theory of ﬁnite mixture, recently, methods
based on this theory performed well in many cases and
applications including character recognition [51], tissue
segmentation [52], application to astronomical data [53,
54, 55] and enzymatic activity in the blood [56].
Once the mixture is ﬁtted, a probabilistic clustering of
the data into a certain number of clusters can be obtained
in termsoftheﬁttedposterior probabilities ofcomponent
membership for the data. The likelihood ratio statistic,
Bayesian information criteria (BIC), Akaike information
criteria (AIC), information complexity criteria (ICOMP),
and others are used to choose the number of clusters if
there is any. A mixture of t-distribution may also be used
instead of mixture of normals in order to provide some
protection against atypical observations, which are preva-
lent in microarray data.
M c L a c h l a ne ta l[ 50] proposed a model-based ap-
proach to the clustering of tissue samples on a very large
number of genes. They ﬁrst select a subset of genes rel-
evant for the clustering of the tissue samples by ﬁtting
mixtures of t distributions to rank the genes in order of
increasing size of the likelihood ratio statistic for the test
of one versus two components in the mixture model. The
use of t component distributions was employed in the
geneselectioninordertoprovidesomeprotectionagainst
atypical observations, which exit in genomics and pro-
teomics data. In this case, the data x to be classiﬁed is
viewed as coming from a mixture of probability distribu-
tions (4), where fk(x|θk = (µk,Σk,γ k)) is a t density with
location µk,positive deﬁnite inner productmatrixΣk,and
γk degrees of freedom is given by
Γ((γk + p)/2)
   Σk
   −1/2
 
3.14 ×γk
 1/2Γ
 
γk/2)
 
1+δ(x,µk;Σk
 
/γk
 (1/2)(γk+p), (5)
where δ(x,µk;Σk) = (x −µk)tΣk(x −µk) denotes the Ma-
halanobis squared distance between x and µk.I fγk > 1, µk
isthemeanofx andγk > 2,γ k(γk−2)−1Σk isitscovariance
matrix.
McLachlan approach was demonstrated on two well-
known data sets on colon and leukemia tissues. The algo-
rithm proposed is used to select relevant genes for cluster-
ing the tissue samples into two clusters corresponding to
healthy and unhealthy tissues.222 H. Bensmail and A. Haoudi 2003:4 (2003)
Weightedvoting(WV)
The weighted voting (WV) algorithm directly applies
the signal-to-noise ratio to perform binary classiﬁcation.
For a chosen feature x of a test sample, it measures its dis-
tance with respect to decision boundary b = (1/2)(µ1 +
µ2), which is located halfway between the average expres-
sion levels of two classes, where µ1 and µ2 are the centers
of the two clusters. If the value of this feature falls on one
side of the boundary, a vote is added to the correspond-
ing class. The vote V(x) = P(g,c)(x − b)i sw e i g h t e db y
the distance between the feature value and the decision
boundary and the signal-to-noise ratio of this feature de-
termined by the training set. The vote for each class is
computedbysumminguptheweightedvotes,V(x),made
by selected features for this class. In this contest, Yeang et
al [57] performed multiclass classiﬁcation by combining
the outputs of binary classiﬁers. Three classiﬁers includ-
ing weighted voting were applied over 190 samples from
14 tumor classes where a combined expression dataset
was generated. Weighted Voting is a classiﬁcation tool
which, based on the already known clusters, proposes a
rule of classiﬁcation of the data set and then predicts the
allocation of new samples to one of the established clus-
ters.
k-nearestneighbors(kNN)
The kNN algorithm is a popular instance-based
method of cluster analysis. The algorithm partitions data
into a predetermined number of categories as instances
are examined, according to a distance measure (eg, Eu-
clidean).Categorycentroidsareﬁxedatrandompositions
when the model is initialized, which can aﬀect the cluster-
ing outcome.
kNN is popular because of its simplicity. It is widely
used in machine learning and has numerous variations
[58]. Given a test sample of unknown label, it ﬁnds the k
nearest neighbors in the training set and assigns the label
of the test sample according to the labels of those neigh-
bors. The vote from each neighbor is weighted by its rank
in terms of the distance to the test sample.
Let Gm = (g1m,g 2m,...,g qm), where gim is the log ex-
pression ratio of the ith gene in the mth specimen; m =
1,...,M(M = number of samples in the training set). In
the kNN method, one computes the Euclidean distance
between each specimen, represented by its vector Gm,a n d
each of the other specimens. Each specimen is classiﬁed
according to the class membership of its k-nearest neigh-
bors. In a study undertaken by Hamadeh et al [59], the
training set comprised of RNA samples derived from liv-
ers of Sprague-Dawley rats exposed to one of 3 peroxi-
some proliferations. In this study, M = 27, q = 30, and
k = 3. A set of q (q = 30) genes was considered discrim-
inative when at least 25 out of 27 specimens were cor-
rectly classiﬁed. A total of 10,000 such subsets of genes
were obtained. Genes were then rank-ordered according
to how many times they were selected into these subsets.
The top 100 genes were subsequently used for prediction
purposes.
kNN can also be used for recovering missing values in
DNA microarray. In fact, hundreds of genes can be ob-
served in one particular experiment. Arrays are printed
with approximately 1 kilobase of DNA, corresponding to
the coding region of a particular gene, per spot. Labelling
of cDNA is done to determine where hybridization oc-
curs. Hybridization is viewed either by ﬂuorescence or ra-
dioactive intensity. One drawback of these techniques is
thescanningofhybridizationintensities.Acertainthresh-
o l dv a l u em u s tb em e ti no r d e rf o rav a l u et ob er e t u r n e d
as a valid measurement. If a value is below this thresh-
old, it is returned as missing data. This missing data dis-
ruptstheanalysisoftheexperiment.Forinstance,ifagene
is printed in a duplicate, over a series of arrays, and one
spot on one array is below the threshold, the gene is dis-
regarded across all arrays. The loss of this gene expression
data is costly because no experimental conclusions can be
made from the loss of expression of this gene over all ar-
rays [60].
Artiﬁcialneuralnetwork(ANN)
Unsupervised neural networks provide a more robust
and accurate approach to the clustering of large amounts
of noisy data. Neural networks have a series of properties
that make them suitable for the analysis of gene expres-
sion and proteins patterns. They can deal with real-world
data sets containing noisy, ill-deﬁned items with irrele-
vant variables and outliers, and whose statistical distribu-
tion does not need to be parametric. Multilayer percep-
trons [61] provide a nonlinear mapping where the real-
valued input x is transformed and mapped to get a real-
valued output y:
x −→ W × x −→ h −→ y, (6)
where W is the weight matrix, called ﬁrst layer, h is a non-
linear transformation, y is a ﬁnished node. The following
is an example of a two-layer neural network:
x =

  

x1
x2
x3
x4

  
 −→ W × x =

    

4  
i=1
αixi
4  
i=1
βixi

    

=
 
α1
α2
 
−→

 

h
 
α1
 
=
1
1+e−α1
h
 
α2
 
=
1
1+e−α2

 
,
y =
2  
i=1
wihi
(7)
if 0 <y<1, then we have a classiﬁcation case with two
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128 subjects
(% lymphocytes)
>19.5 ≤19.5
A. Class 2 (node)
1 class 1
45 class 2
82 subjects
Reactivity to pokeweed mitogen
≤9.9165 >9.9165
15 subjects
Scaled number of T8 Cells
≤0.3705 >0.3705
D. Class 1 (node)
59 class 1
8 class 2
B. Class 1 (node)
3 class 1
2 class 2
C. Class 2 (node)
1 class 1
9 class 2
Figure 1. An example of neural network black box: a four-dimensional data input x is ﬁrst transformed by W, then by h in order to
give a grouping variable y as an output.
by comparing y = h(x) with a threshold, we suppose here
0 for simplicity, if h(x) > 0, observation x belongs to the
cluster 1, if h(x) < 0, then x belongs to cluster 2. The
weights W are estimated by examining the training points
sequentially.
ANNhasbeenappliedtoanumberofdiverseareasfor
the identiﬁcation of “biologically relevant” molecules, in-
cluding pyrolysis mass spectrometry [62] and genomics
microarraying of tumor tissue [63]. Ball et al [64]u t i -
lized a multilayer perceptron with a back propagation al-
gorithmfortheanalysisofSELDImassspectrometrydata.
This type of ANN is a powerful tool for the analysis of
complex data [65]. Wei et al [66] used the same algo-
rithm for data containing a high background noise. ANN
can be used to identify the inﬂuence of many interacting
factors [67] that makes it highly suitable for the study of
ﬁrst-generationSELDI-deriveddata.Itcanbeusedforthe
classiﬁcationofhumantumorsandrapididentiﬁcationof
potential biomarkers [64]. ANN can produce generalized
models with a greater accuracy than conventional statis-
tical techniques in medical diagnostics [68, 69] without
relyingonpredeterminedrelationshipsasinothermodel-
ing techniques. Usually, the data needs to be trained when
using ANN to predict tumor grade; also the choice of the
numberoflayershastobeproposed.Currently,ANNdoes
not propose criteria for choosing the number of layers
which should be investigator-proposed. A criteria has to
be developed for the ANN to choose the adequate num-
ber of layers.
For the probabilistic modeling, usually the normality
is assumed, whereas in the ANN the data is distribution-
free, which makes the ANN a powerful tool for data anal-
ysis [70].
Hierarchicalclusteringanddecisiontree
Thebasicideaofthetreeistopartitiontheinputspace
recursively into two halves and approximate the function
in each half by the average output value of the samples
it contains [71]. Each bifurcation is parallel to one of the
axes and can be expressed as an inequality involving the
input components (eg, xk >a ). The input space is divided
into hypertangles organized into a binary tree where each
branch is determined by the dimension (k) and boundary
(a) which together minimize the residual error between
model and data.
Example
In a study undertaken by Robert Dillman at the Uni-
versity of California, San Diego Cancer Center [72], 21
continuous laboratory variables related to immunocom-
petence,age,sex,andsmokinghabitsinanattempttodis-
tinguish patient with cancer. Prior probabilities are cho-
sen to be equal: π(1) = π(2) = 0.5, and C(1|2), the cost
of misclassiﬁcation, was calculated. The tree in Figure 1
summarizestheclassiﬁcationof128observationsintotwo
classes: supposedly healthy and unhealthy.
Currently, hierarchical clustering is the most popu-
lar technique employed for microarray data analysis and
gene expression [73]. Hierarchical methods are based on
building a distance matrix summarizing all the pairwise
similarities between expression proﬁles, and then gener-
ating cluster trees (also called dendrograms) from this
matrix. Genes which appear to be coexpressed at various
time points are positioned close to one another in the tree
whose branches lengths represent the degree of similarity
between expression proﬁles.
Decision trees [74] were used to classify proteins as
either soluble or insoluble, based on features of their
amino acid sequences. Useful rules relating these features
with protein solubility were then determined by tracing
the paths through the decision trees. Protein solubility
strongly inﬂuences whether a given protein is a feasible
targetforstructuredetermination,sotheabilitytopredict
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high-throughput projects. These techniques have already
been applied to the study of gene expression patterns
[73]. Neverthless, classical hierarchical clustering presents
drawbacks when dealing with data containing a nonnegli-
gibleamountofnoise.Hierarchicalclusteringsuﬀersfrom
a lack of robustness and solutions may not be unique and
dependent on the data order. Also, the deterministic na-
ture of hierarchical clustering and the impossibility of re-
evaluating the results in the light of the complete data can
c a u s es o m ec l u s t e r so fp a t t e r n st ob eb a s e do nl o c a ld e c i -
sions rather than on the global picture.
Self-organizingmapping(SOM)
The self-organizing feature map (SOM) [75] consists
of a neural network whose nodes move in relation to cat-
egory membership. As with k-means, a distance measure
is computed to determine the closest category centroid.
Unlike k-means, this category is represented by a node
with an associated weight vector. The weight vector of the
matching node, along with those of neighboring nodes,
is updated to more closely match the input vector. As
data points are clustered and category centroids are up-
dated, the positions of neighboring nodes move in rela-
tion to them. The number of network nodes which con-
stitute this neighborhood typically decreases over time.
The input space is deﬁned by the experimental input
data, whereas the output space consists of a set of nodes
arranged according to certain topologies, usually two-
dimensional grids. The application of the algorithm maps
the input space onto the smaller output space, produc-
ing a reduction in the complexity of the analyzed data set
[76, 77]. Like PCA, the SOM is capable of reducing high-
dimensional data into a 1- or 2-dimensional representa-
tion. The algorithm produces a topology-preserving map,
conserving the relationships among data points. Thus, al-
though either method may be used to eﬀectively parti-
tion the input space into clusters of similar data points,
the SOM can also indicate relationships between clus-
ters.
SOM is reasonably fast and can be easily scaled to
large data sets. They can also provide a partial structure
of clusters that facilitate the interpretation of the results.
SOM structure, unlike the case of hierarchical cluster, is a
two-dimensional grid usually of hexagonal or rectangular
g e o m e t r y ,h a v i n gan u m b e ro fn o d e sﬁ x e df r o mt h eb e -
ginning. The nodes of the network are initially random
patterns. During the training process, that implies slight
changes in the nodes after repeated comparison with the
data set, the node changes in a way that captures the dis-
tribution of variability of the data set. In this way, similar
g e n e ,p e a k ,p r o t e i np r o ﬁ l ep a t t e r n sm a pc l o s et o g e t h e ri n
the network and, as far as possible from the diﬀerent pat-
terns.
A combination of SOM and decision tree was pro-
posed by Herrero et al [78]. The description of the algo-
rithm is given as follows: given the patterns of expression
that has to be classiﬁed, if two genes are described by their
expression patterns as g1(e11,e 12,...,e 1n)a n dg2(e21,e 22,
...,e 2n) and their distance d1,2 =
  
(e1i − e2i)2, the ini-
tial system of the SOM is composed of two external el-
ements, connected by an internal element. Each cell is a
vector with the same size as the gene proﬁles. The entries
of the two cells and the node are initialized. The network
is trained only through their terminal neurons or cells.
The algorithm proceeds by expanding the output topol-
ogy starting from the cell having the most heterogeneous
population of associated input gene proﬁles. Two new de-
scendents are generated from this heterogeneous cell that
changes its state from cell to node. The series of opera-
tions performed until a cell generates two descendents is
called a cycle. During a cycle, cells and nodes are repeat-
edly adapted by the input gene proﬁles. This process of
successive cycles of generation of descendant cells can last
until each cell has one single input gene proﬁle assigned
(or several, identical proﬁles), producing a complete clas-
siﬁcation of all the gene proﬁles. Alternatively, the expan-
sion canbe stopped atthe desired level of heterogeneity in
the cells, producing in this way a classiﬁcation of proﬁles
at a higher hierarchical level.
Kanaya et al [79]u s eS O Mt oe ﬃciently and compre-
hensively analyze codon usage in approximately 60,000
genes from 29 bacterial species simultaneously. They
showed that SOM is an eﬃcient tool for characteriz-
ing horizontally transferred genes and predicting the
donor/acceptor relationship with respect to the trans-
ferred genes. They examined codon usage heterogeneity
in the Ec o l iO157 genome, which contains the unique
segments including O-islands [81]thatareabsentinEco l i
K 12.
Supportvectormachine(SVM)
SVM originally introduced by Vapnik and cowork-
ers [82, 83] is a supervised machine learning technique.
SVMs are a relatively new type of learning algorithms
[84, 85] successively extended by a number of researchers.
Their remarkably robust performance with respect to
sparse and noisy data is making them the system of choice
in a number of applications from text categorization to
protein function prediction. SVM has been shown to per-
form well in multiple area of biological analysis includ-
ing evaluating microarray expression data [86], detect-
ing remote protein homologies, and recognizing transla-
tion initiation sites [87, 88, 89]. When used for classiﬁ-
cation, they separate a given set of binary-labeled train-
ing data with a hyperplane that is maximally distant from
them known as “the maximal margin hyperplane.” For
cases in which no linear separation is possible, they can
work in combination with the technique of “kernels” that
automatically realizes a nonlinear mapping to a feature
space.
TheSVMlearningalgorithmﬁndsahyperplane(w,b)
such that the margin γ is maximized.The margin γ is de-
ﬁnedasafunctionofdistancebetweentheinputx,labeled
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boundary ( w,φ(x) −b):
γ = min
x sign
  
w,φ(x)
 
−b
 
, (8)
whereφ isamappingfunctionfromtheinput spacetothe
feature space.
The decision function to classify a new input x is
f(x) = sign
  m  
i=1
αiyi
 
φ(xi),φ(x)
 
−b
 
. (9)
When the data is not linearly separable, one can use
more general functions that provide nonlinear decision
boundaries, like polynomial kernels
Kij =
 
φ(xi),φ(xj)
 
=
 
 xi,xj +1
 p (10)
or Gaussian kernels Kij = e− xi−xj /σ2,w h e r ep and σ are
kernel parameters.
To apply the SVM for gene classiﬁcation, a set of ex-
amples was assembled containing genes of known func-
tion, along with their corresponding microarray expres-
sion proﬁles. The SVM was then used to predict the
functions of uncharacterized yeast open reading frames
(ORFs) based on the expression-to-function mapping es-
tablished during training [86]. Supervised learning tech-
niques appear to be ideal for this type of functional classi-
ﬁcation of microarray targets, where sets of positive and
negative examples can be compiled from genomic se-
quence annotations.
Booleannetwork
The basis for the Boolean networks was introduced by
Turing and von Neumann in the form of automata the-
ory [90, 91]. A Boolean network is a system of n inter-
connected binary elements; any element in the system can
be connected to a series I of other k elements, where k
(and hence I) can vary. For each individual element, there
is a logical or Boolean rule B which computes its value
based on the values of elements connected with one. The
state of the system S is deﬁned by the pattern of states
(on/oﬀ or 0/1) of all elements. All elements are updated
synchronously, moving the system into its next state, and
each state can have only one resultant state. The total sys-
tem space is deﬁned as all possible N combinations of the
values of the n elements in S.
One of the important types of information underly-
ing the expression proﬁle data is the regulatory networks
among genes, which is called also “genetic network.”
Modeling with the Boolean network [92, 93, 94, 95]h a s
been investigated for inferences of the genetic networks.
Tavazoie et al [96] proposed an approach that combines
cluster analysis with sequence motif detection to deter-
mine the genetic network architecture. Recently, an ap-
proach to infer the genetic networks with Bayesian net-
works was proposed [97] but still a little has been done in
this area using Boolean network.
Combinationofclusteranalysisandagraphical
Gaussianmodeling(GGM)
GGM is an algorithm that was proposed by Toh and
Horimoto [98] to cluster expression proﬁle data. GGM is
a multivariate analysis to infer or test a statistical model
for the relationship among a plural of variables, where a
partial correlation coeﬃcient, instead of a correlation co-
eﬃcient, is used as a measure to select the ﬁrst type of
interaction [99, 100]. In GGM, the statistical model for
the relationship among the variables is represented as a
graph, called the “independence graph,” where the nodes
correspond to the variables under consideration and the
edges correspond to the ﬁrst type of interaction between
variables. More speciﬁcally, an edge in the independence
graph indicates a pair of variables that are conditionally
dependent. GGM was applied for the expression proﬁle
data of 2467 Saccharomyces cerevisiae genes measured un-
der79diﬀerentconditions[73].The2467geneswereclas-
siﬁed into 34 clusters by a cluster analysis, as a preprocess-
ing for GGM. Then the expression levels of the genes in
each cluster were averaged for each condition. The aver-
aged expression proﬁle data of 34 clusters were subjected
to GGM and a partial correlation coeﬃcient matrix was
obtained as a model of the genetic network of the Sc e r e -
visiae.
Otherprobabilisticandclusteringmethods
andapplications
To try to make a sense to microarray data distribu-
tions, Hoyle et al [101] proposed a comparison of the en-
tire distribution of spot intensities between experiments
and between organisms. The novelty of this study is by
showingthatthereisacloseagreementwithBenford’slaw
and Zipf’s law [102, 103] which is a combination of log-
normal distribution of large majority of the spot intensity
values and the Zipf’s law for the tail.
In addition to the clustering methods that we have de-
scribed, there exist numerous other methods. Bensmail
and Celeux [104] used model-based cluster analysis to
cluster242casesofvariousgradesofneoplasiawhichwere
collected and diagnosed in a subsequently taken biopsy
[105]. There were 50 cases with mild displasia, 50 cases
with moderate displasia, 50 cases with severe displasia, 50
cases with carcinoma in situ, and 42 cases with invasive
carcinoma. Eleven measurements were used in this study,
7 are ordinal and 4 are numerical. Using eigenvalue de-
composition regularized discriminant analysis algorithm
(EDRDA), 14 models were investigated and their perfor-
mance was measured by their error rate of misclassiﬁca-
tionwithcross-validation.Eachmodeldescribesaspeciﬁc
orientation, shape, and volume of the cluster deﬁned by
the spectral decomposition of the covariance matrix Σk
related to each cluster:
Σk = λkDkAkDt
k, (11)226 H. Bensmail and A. Haoudi 2003:4 (2003)
Table 1. Summary of the 14 models presented in Bensmail and Celeux [104].
Model 1 =
 
λDADt 
Model 2 =
 
λkDADt 
Model 3 =
 
λDAkDt 
Model 4 =
 
λkDAkDt 
Model 5 =
 
λDkADt
k
 
Model 6 =
 
λkDkADt
k
 
Model 7 =
 
λDkAkDt
k
 
Model 8 =
 
λkDkAkDt
k
 
Model 9 = [λI]M o d e l 1 0 =
 
λkI
 
Model 11 = [λB]M o d e l 1 2 =
 
λkB
 
Model 13 =
 
λBk
 
Model 14 =
 
λkBk
 
Table 2. Summary of the properties of the most commonly applied algorithms for data analysis.
Time/space Strengths Weaknesses
PCA
 
p(p +1 )/2
 
Dimension reduction Circular shape
p:n o .o fv a r i a b l e s
Unsupervised learning
normal mixture
 
kp2n
 
/ O(kn)
Clustering and prediction Normality assumption p:n o .o fv a r i a b l e s
k:n o .o fc l u s t e r s
Weighted voting
(kp) Tailored weights
Binary classiﬁcation p:n o .o fv a r i a b l e s Weights ﬂexibility
k:n o .o fc l u s t e r s
kNN
(tkn)
Image processing Known mean k:n o .o fc l u s t e r s
Handling missing data Known number of classes n:n o .o fo b s e r v a t i o n s
t: no. of iterations
ANN
O(n) Nonlinear/Noisy data Black box behavior
n:n o .o fo b s e r v a t i o n s
Hierarchical/tree
O
 
n2 
Readability of results Numerical data only
n: no. of observations No scaling of data
SOM
O(n)
Topology preserving
Trained on normal data
No reliability n:n o .o fo b s e r v a t i o n s
Computationally tractable
Handling high dimension
SVM
O
 
n2 
Easy training
Need to a kernel function
n: no. of observations Handling high-dimensional data
Boolean network
O
 
n(d)
 
Deﬁning relationships No handling of missing data
Trained on large data n:n o .n o d e s
d: max(indegree)
GGM
O
 
kp2 
Probabilistic model Conditional probability k:n o .o fc l u s t e r s Graphical model
p:n o .o fv a r i a b l e s
Model-based
O
 
kp2n
 
Geometry of the clusters Normality k:n o .o fc l u s t e r s
n:n o .o fo b s e r v a t i o n s
p:n o .o fv a r i a b l e s
where λk =| Σk|1/p describes the volume of the cluster Gk,
Dk, the eigenvectors matrix, describes the orientation of
the cluster Gk,a n dAk, the eigenvalues matrix, describes
the shape of the cluster Gk. Table 1 summarizes the four-
teen models.
This methodology seems very promising since it took
in consideration the characteristics of the clusters (shape,
volume, and orientation) and then proposed a ﬂexible
way of discriminating the data by proposing a panoply
of rules varying from the simple one (linear discrimi-
nant rule) to the complex one (quadratic discriminant
rule). This methodology can easily be applied to discrim-
inate/classify peaks of protein proﬁles when they are ap-
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assumption that the data is distributed according to a
mixture of Gaussian distributions, some extent to which
diﬀerent transformations of gene expression or protein
proﬁles sets satisfying the normality assumption may
be explored. Three commonly used transformations can
be applied: logarithm, square root, and standardization
(wherein the raw expression levels for each gene [protein
proﬁle] are transformed by substracting their mean and
dividing by their standard deviation) [106]. Other more
interesting transformations may be investigated including
kernel smoother.
The summary of the above-described methods for
clustering, classiﬁcation, and prediction of gene expres-
sion and protein proﬁles sets is presented in Table 2.W e
presentthealgorithms,theirperformance,theirstrengths,
and weaknesses. Over all, some methods are eﬃcient for
someapplicationssuchasimputingdatabutperformsless
in clustering. Probabilistic methods such as model-based
methods and mixture models are interesting to look at af-
ter transforming the data sets because they are a natural
ﬁt to cluster data sets with underlying distribution. Non-
probabilistic methods such as the Neural network and the
Kohonen mapping may be interesting when the data con-
tains an important amount of noise.
CONCLUSION
The postgenomic era holds phenomenal promise for
identifying the mechanistic bases of organismal develop-
ment, metabolic processes, and disease, and we can con-
ﬁdently predict that bioinformatics research will have a
dramaticimpactonimprovingourunderstandingofsuch
diverse areas as the regulation of gene expression, protein
structuredetermination,comparativeevolution,anddrug
discovery.
Software packages and bioinformatic tools have been
and are being developed to analyze 2D gel protein pat-
terns. These software applications possess user-friendly
interfaces that are incorporated with tools for lineariza-
tion and merging of scanned images. The tools also help
in segmentation and detection of protein spots on the im-
ages, matching, and editing [107]. Additional features in-
clude pattern recognition capabilities and the ability to
perform multivariate statistics. The handling and analy-
sis of the type of data to be collected in proteomic inves-
tigations represent an emerging ﬁeld [Bensmail H, Hes-
pen J. Semmes OJ, and Haudi A. Fast Fourier trans-
form for Bayesian clustering of Proteomics data (unpub-
lisheddata).].Newtechniquesandnewcollaborationsbe-
tween computer scientists, biostatisticians, and biologists
are called for. There is a need to develop and integrate
database repositories for the various sources of data being
collected, to develop tools for transforming raw primary
data into forms suitable for public dissemination or for-
mal data analysis, to obtain and develop user interfaces to
store, retrieve, and visualize data from databases and to
develop eﬃcient and valid methods of data analysis.
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